October 01, 2024

Med Ed: 36 Nutrition Competencies Recommended

A consensus panel of medical education experts identified 36 nutrition competencies recommended for inclusion in undergraduate and graduate medical education curricula in the U.S.

Conexiant

September 27, 2024

Datopotamab Deruxtecan vs Docetaxel in Previously Treated Advanced or Metastatic NSCLC

As reported in the Journal of Clinical Oncology by Ahn et al, the phase III TROPION-Lung01 trial showed significantly improved progression-free survival—but not overall survival—with datopotamab derux...

The ASCO Post

September 26, 2024

FDA Approves Osimertinib in Stage III NSCLC After Chemoradiotherapy

The U.S. Food and Drug Administration approved osimertinib (Tagrisso) for adults with locally advanced, unresectable (stage III) non–small cell lung cancer (NSCLC) whose disease has not progressed dur...

The ASCO Post

September 26, 2024

HARMONi-2: Ivonescimab Outperforms Pembrolizumab as First-Line Treatment in NSCLC

In the phase III HARMONi-2 study conducted in China, presented at the IASLC 2024 World Conference on Lung Cancer, the bispecific antibody ivonescimab was compared with the PD-1 inhibitor pembrolizumab...

The ASCO Post

September 25, 2024

Cancer Rates Recover, Rebound Eludes 2021 Data

Cancer rates returned to near prepandemic levels in 2021, however, distant-stage breast cancer incidence surpassed expectations, signaling potential COVID-19 screening disruption effects.

Conexiant

September 20, 2024

FDA Approves Amivantamab-vmjw With Carboplatin and Pemetrexed for Non–Small Cell Lung Cancer With EGFR Exon 19 Deletions or L858R Mutations

The U.S. Food and Drug Administration (FDA) approved amivantamab-vmjw (Rybrevant) with carboplatin and pemetrexed for adults with locally advanced or metastatic non–small cell lung cancer (NSCLC) with...

The ASCO Post

September 19, 2024

Pesticide Patterns Linked to Elevated Cancer Rates

Nationwide study reveals agricultural pesticide use patterns may contribute to over 150,000 additional cancer cases annually, rivaling smoking's impact for certain cancer types.

Conexiant

September 18, 2024

Childhood Stress Linked to Adult Health Outcomes

Childhood adversity linked to 18 out of 20 major health conditions in adulthood, with sex-specific effects.

Conexiant

September 16, 2024

Immunotherapy Boosts Long-Term Cancer Survival Rates

Immunotherapy shows promise for potential cure in advanced melanoma, with 96% of long-term responders surviving 10 years without melanoma recurrence.

Conexiant